MCL1 and non-small cell lung carcinoma: This study provides mechanistic evidence that cabozantinib enhances radiation-induced ferroptosis in NSCLC cells through a pathway involving the suppression of STAT3/MCL1, activation of BECN1, and inhibition of SLC7A11.